Veljan Denison has moved to modernize its corporate governance framework and expand its operational scope. The Board of Directors, meeting on August 3, 2026, approved the adoption of new Memorandum of Association (MOA) and Articles of Association (AOA) aligned with the Companies Act, 2013. Crucially, the Board also authorized an alteration to the Main Objects Clause of the MOA by inserting a new Sub-Clause 5, enabling the company to undertake additional business activities incidental to its future growth and diversification plans. These changes require shareholder approval via Special Resolution at the upcoming Annual General Meeting (AGM).

The existing constitutional documents were based on the Companies Act, 1956. The shift to the 2013 Act framework ensures compliance with current regulatory standards. The insertion of Sub-Clause 5 under Clause III(A) is designed to facilitate expansion into new business opportunities, providing the flexibility needed for strategic diversification beyond its core Hydraulic Products segment. The amendments will become effective upon shareholder approval and the filing of requisite e-forms with the Registrar of Companies.

Governance and Shareholder Actions

The Board’s decision forms part of a broader set of governance updates approved during the August 3 meeting, which also saw the approval of Q1FY27 financial results. In addition to the MOA and AOA changes, shareholders will vote on the re-appointment of Dr. Suresh Akella as a Non-Executive Independent Director for a second five-year term, effective September 30, 2026. Mr. V. G. Srinivas, retiring by rotation, has also offered himself for re-appointment. M/s. SRK & Co., Cost Accountants, was re-appointed as Cost Auditor for FY27, subject to member ratification of remuneration.

Financial Context and AGM Details

These structural changes come against a backdrop of stable financial performance. Veljan Denison reported a standalone net profit of ₹746.19 lakh for Q1FY27, a 5% year-on-year increase. Consolidated revenue from operations grew 2% to ₹434.75 lakh. The Board recommended a dividend payment, with the record date fixed for August 22, 2026. The Register of Members and Share Transfer Books will remain closed from August 23, 2026, to August 29, 2026, inclusive.

The 52nd Annual General Meeting is scheduled for August 29, 2026, at 11:00 A.M. at the company's registered office in Hyderabad. Remote e-voting will be conducted under the scrutiny of Chakravarthy & Associates, Practicing Company Secretaries. Statutory Auditors Brahmayya & Co. issued an unmodified limited review report on the quarterly results, which were disclosed under Regulation 30 and Regulation 33(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Veljan Denison Limited has approved the re-appointment of Dr. Suresh Akella as a Non-Executive Independent Director for a second consecutive term, subject to shareholder approval. The Board made the decision at its meeting held on August 3, 2026, based on the recommendation of the Nomination and Remuneration Committee. The new term is scheduled to commence on September 30, 2026, and will run until September 29, 2031. This appointment ensures continuity in independent oversight for the Hyderabad-based manufacturing company.

The move follows a review of Dr. Akella’s qualifications, expertise, and experience in Manufacturing and F&E (Fabrication & Erection). The Board determined that his continued association remains beneficial to the Company’s strategic guidance and governance. The re-appointment must be ratified by shareholders through a Special Resolution. Until such approval is granted, the appointment remains conditional.

Appointment Details

The key parameters of the proposed re-appointment are outlined below:

Regulatory Compliance and Independence

The disclosure was made pursuant to Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The Company also cited compliance with SEBI Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024. The Board confirmed that Dr. Akella satisfies the criteria of independence prescribed under the Companies Act, 2013 and the SEBI Listing Regulations.

Furthermore, the Company stated that Dr. Akella is not related to any other Director of the Company. He is also not debarred from holding the office of Director by virtue of any order passed by the Securities and Exchange Board of India or any other authority. The Nomination and Remuneration Committee recommended the re-appointment after verifying these independence criteria.

Profile and Expertise

Dr. Suresh Akella brings extensive experience in the Manufacturing and F&E sectors to the Board. His profile highlights significant expertise in technology and industry applications. The Board noted his valuable contributions through strategic guidance and independent oversight during his previous term. This background aligns with the Company’s operational focus and governance requirements for its independent directorship roles.